CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients

Guideline2018 Oct 31.

JOURNAL:Heart Rhythm. Article Link

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Kusumoto FM, Schoenfeld MH, Barrett C et al. Keywords: bradycardia; cardiac conduction delay; guideline; ACC; AHA

FULL TEXT PDF